(Reuters) -Merck & Co Inc said on Monday it will acquire cancer drug developer Imago BioSciences Inc for a total equity value of $1.35 billion to expand its portfolio of blood disorder treatments. The ...
REDWOOD CITY, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. ("Imago") (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering and developing new medicines for the ...
Imago Biosciences (US:IMGO) took center stage on Monday, rising 104.5% after noting it had received a takeover offer from pharmaceutical giant Merck (US:MRK) in a deal worth around $1.35 billion.
Imago relationship therapy is a form of couples counseling and coaching designed to help relationship partners work out misunderstandings, reduce conflict, and rediscover ways to bond, communicate, ...
Shares of Imago BioSciences Inc. soared 104.9% into record territory in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and ...
Integrating Cloud-based Geoscientific Imagery Platform with Geology Data Management and Modeling Tools, Helping Solve Earth, Environment, and Energy Challenges EXTON, Pa.--(BUSINESS WIRE)--Bentley ...
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, New Jersey · Reuters The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment ...
Imago relationship therapy is a form of couples counseling and coaching designed to help relationship partners work out misunderstandings, reduce conflict, and rediscover ways to bond, communicate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results